Desano owns multiple production bases for pharmaceutical preparations, active pharmaceutical ingredients (APIs) and intermediates in Pudong (Shanghai), Yancheng (Jiangsu), Zhangshu (Jiangxi), Anyang (Henan), Xianju (Zhejiang) and other locations. All these bases comply with cGMP and EHS requirements. Each production base is equipped with first-class production facilities, has established international-standard quality and EHS management systems, and employs a professional management team.

The company’s key production bases have successively passed quality audits conducted by numerous national and international regulatory authorities, including China’s NMPA, WHO-PQ of the World Health Organization, the U.S. FDA, the UK MHRA, the European EMA and EDQM, Australia’s TGA, Brazil’s ANVISA, and Mexico’s COFEPRIS. All major production bases of the company have obtained ISO14001 and ISO45001 certifications.